Overview
TECH market data
Price History
TECH price chart
Valuation & Profitability
- P/E (TTM)
- 103.97 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.46 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.28 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 44.4% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $43.20 – $72.37 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $11.3K · P/B 4.20 · P/S 9.31.
Company News
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible TakeoverBenzinga · Jul 10, 2026, 1:30 PM
RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73Benzinga · Jul 9, 2026, 3:25 PM
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their ShareholdersGlobenewswire Inc · Jul 6, 2026, 6:15 PM
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73Benzinga · Jun 30, 2026, 1:40 PM
Benchmark Downgrades Bio-Techne to HoldBenzinga · Jun 30, 2026, 1:20 PM
Citigroup Downgrades Bio-Techne to Neutral, Raises Price Target to $73Benzinga · Jun 29, 2026, 1:15 PM
Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73Benzinga · Jun 26, 2026, 3:30 PM
William Blair Downgrades Bio-Techne to Market PerformBenzinga · Jun 26, 2026, 2:55 PM
Baird Maintains Neutral on Bio-Techne, Raises Price Target to $73Benzinga · Jun 26, 2026, 11:25 AM
8-K filing — BIO-TECHNE Corp (TECH)SEC EDGAR · Jun 25, 2026, 10:49 PM